Clinical Cardiology 1510 - Clinical Cardiology Alert - Oct 01, 2011

Target Audience:

This activity is intended for the cardiologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Michael H. Crawford, MD
Professor of Medicine
Chief of Cardiology
University of California
San Francisco

Managing Editor
Neill Kimball

Executive Editor
Leslie Coplin

Editorial Board Members
Andrew J. Boyle, MBBS, PhD
Assistant Professor of Medicine
Interventional Cardiology
University of California
San Francisco

John P. DiMarco, MD, PhD
Professor of Medicine
Division of Cardiology
University of Virginia
Charlottesville

Peer Reviewer
Ethan Weiss, MD
Assistant Professor of Medicine
Division of Cardiology and CVRI
University of California, San Francisco

Subjects:

  • Risk of Cardiac Events After Surgery
  • New Oral Anticoagulant for Atrial Fibrillation
  • Subclinical Stroke in AF Ablation
  • ACE Inhibitors/ARBs for Aortic Stenosis?
  • Progression of Diastolic Dysfunction Predicts Incident Heart Failure

Objectives:

  • to present the latest information regarding diagnosis and treatment of cardiac disease
  • to discuss the pros and cons of these interventions, as well as possible complications
  • to discuss the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • to present current data regarding outpatient care of cardiac patients

Financial Disclosure:

Clinical Cardiology Alert's Editor, Michael H. Crawford, MD, reports no financial relationships relevant to this field of study, and peer reviewer, Ethan Weiss, MD, is a scientific advisory board member for Bionovo. Editorial board member Andrew J. Boyle, MBBS, PhD, Managing Editor, Neill Kimball, and Executive Editor, Leslie Coplin, report no financial relationships relevant to this field of study. Editorial board member John P. DiMarco, MD, PhD does research for Medtronic, is a consultant for Medtronic, Novartis, and St. Jude, and is a speaker for Boston Scientific.

Copyright 2011 AHC Media LLC. All rights reserved.